Back to search results

Registry for Bone Metastases

This study is an international patient registry (a database of health information) for people with symptomatic bone metastases (cancer that has spread to the bones and is causing symptoms). The goal is to learn more about this condition. You may be able to join if you are at least 22 years old and have bone metastases that have been confirmed by a biopsy or are clearly visible, and you need treatment for a symptomatic bone lesion. This study aims to understand overall survival (how long people live) over 10 years. The current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will collect information without providing specific treatments. It plans to enroll 500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed to measure overall survival at 10 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07391410

Registry for Bone Metastases

Recruiting
Not specifiedAges 22+Observational
Memorial Sloan Kettering Cancer Center
~500 participants
Updated 2026-08-20 on ClinicalTrials.gov

At a glance

Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
overall survival
Measured over 10 years

Conditions

Bone Metastases

Explore related trials

Metastatic Malignant Neoplasm in the BoneMultiple Myeloma

NCT07391410

Where you'd take part

This study runs at 7 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

    Basking Ridge, New Jerseystudy coordinator listed

    Recruiting

  • Memorial Sloan Kettering Bergen (All Protocol Activities)

    Montvale, New Jerseystudy coordinator listed

    Recruiting

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New Yorkstudy coordinator listed

    Recruiting

  • Memorial Sloan Kettering Monmouth (All Protocol Activities)

    Middletown, New Jerseystudy coordinator listed

    Recruiting

  • Memorial Sloan Kettering Nassau (All Protocol Activities)

    Uniondale, New Yorkstudy coordinator listed

    Recruiting

  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)

    Commack, New Yorkstudy coordinator listed

    Recruiting

  • Memorial Sloan Kettering Westchester (All Protocol Activities)

    Harrison, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Jonathan Forsberg, MD, PhD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

Jonathan Forsberg, MD, PhD
[email protected]
212-639-2076
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥22 years
Biopsy-proven or clinically obvious metastatic bone disease . For purposes of this study, metastatic bone disease includes skeletal involvement from multiple myeloma.
Symptomatic bone lesion requiring intervention
This includes but is not limited to radiotherapy, cryotherapy, radiofrequency ablation, operative fixation, prosthetic replacement, amputation, or any combination of the above

Exclusion

Age \<22 years

What this trial measures

  • overall survival10 years